摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

异丙戊二胺喹 | 86-78-2

中文名称
异丙戊二胺喹
中文别名
喷他喹;丙戊喹;戊喹戊胺喹
英文名称
N-isopropyl-N'-(6-methoxy-[8]quinolyl)-pentanediyldiamine
英文别名
N-Isopropyl-N'-(6-methoxy-[8]chinolyl)-pentandiyldiamin;N-(6-methoxy-8-quinolinyl)-N'-(1-methylethyl)-1,5-pentanediamine;Pentaquine;N-(6-methoxyquinolin-8-yl)-N'-propan-2-ylpentane-1,5-diamine
异丙戊二胺喹化学式
CAS
86-78-2
化学式
C18H27N3O
mdl
——
分子量
301.432
InChiKey
VKXQZROIIKPELG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    442.55°C (rough estimate)
  • 密度:
    1.0656 (rough estimate)
  • 保留指数:
    2540;2555

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    22
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险等级:
    6.1(b)
  • 包装等级:
    III
  • 危险类别:
    6.1(b)
  • 危险品运输编号:
    UN 1544

SDS

SDS:a6f1ccf54965fe2fc1269bcc2b67fb88
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    异丙戊二胺喹四(三苯基膦)钯 、 tetra-N-butylammonium tribromide 、 碳酸氢钠 作用下, 以 乙醇甲苯 为溶剂, 生成 N-(5-Furan-2-yl-6-methoxy-quinolin-8-yl)-N'-isopropyl-pentane-1,5-diamine
    参考文献:
    名称:
    8-Aminoquinolines as anticoccidials-I
    摘要:
    The proposed ring metabolites of the 8-aminoquinoline antimalarial, pentaquine, 1, have been synthesised and their biological activity as anticoccidial agents investigated in vivo. Several analogues in which this metabolic pathway had been blocked were also synthesised and their anticoccidial activity measured. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(97)10024-5
  • 作为产物:
    描述:
    8-氨基-6-甲氧基喹啉 在 lithium aluminium tetrahydride 、 sodium cyanoborohydride 、 三乙胺 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 24.0h, 生成 异丙戊二胺喹
    参考文献:
    名称:
    8-aminoquinolines as anticoccidials - part III
    摘要:
    Analogues of the antimalarial pentaquine, 1, in which the nature of the side-chain on the 8-amino position was varied, were prepared and evaluated for anticoccidial activity both in vitro and in vivo. Specifically, both the inter-nitrogen distance and the nature of the terminal amino group were investigated. Novel analogues of equal or improved efficacy in vitro and in vivo to pentaquine were discovered. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(99)00393-5
点击查看最新优质反应信息

文献信息

  • Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling
    作者:Thota Ganesh、Jaeki Min、Pahk Thepchatri、Yuhong Du、Lian Li、Iestyn Lewis、Larry Wilson、Haian Fu、Gabriela Chiosis、Raymond Dingledine、Dennis Liotta、James P. Snyder、Aiming Sun
    DOI:10.1016/j.bmc.2008.05.047
    日期:2008.7
    The molecular chaperone Hsp90 plays important roles in maintaining malignant phenotypes. Recent studies suggest that Hsp90 exerts high-affinity interactions with multiple oncoproteins, which are essential for the growth of tumor cells. As a result, research has focused on finding Hsp90 probes as potential and selective anticancer agents. In a high-throughput screening exercise, we identified quinoline
    分子伴侣 Hsp90 在维持恶性表型中起重要作用。最近的研究表明,Hsp90 与多种癌蛋白产生高亲和力相互作用,这对肿瘤细胞的生长至关重要。因此,研究的重点是寻找 Hsp90 探针作为潜在和选择性的抗癌剂。在高通量筛选练习中,我们将喹啉 7 鉴定为 Hsp90 的中度抑制剂。进一步的命中识别、SAR 研究和生物学调查揭示了该系列中的几种合成类似物在荧光偏振 (FP) 测定和基于细胞的蛋白质印迹 (WB) 测定中均具有微摩尔活性。这些化合物代表了一类具有简单化学结构的新型 Hsp90 抑制剂。
  • Diagnostic/therapeutic agents
    申请人:Klaveness Jo
    公开号:US20050002865A1
    公开(公告)日:2005-01-06
    Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.
    可定位的诊断和/或治疗活性剂,例如超声对比剂,包括悬浮在水载体液中的报告物,该报告物包含含气体或生成气体的材料,该剂能够与目标形成至少两种结合对。
  • Method for producing L-amino acids by fermentation
    申请人:——
    公开号:US20020102665A1
    公开(公告)日:2002-08-01
    The present invention provides an industrially efficient method for producing an L-amino acid useful as medicament, chemical agent, food material and feed additive, and the method comprising culturing in a medium a microorganism having an ability to produce the L-amino acid and having resistance to a DNA gyrase inhibitor or a microorganism having an ability to produce the L-amino acid and having both resistance to a DNA gyrase inhibitor and resistance to an aminoquinoline derivative, producing and accumulating the L-amino acid therein and recovering the L-amino acid therefrom.
    本发明提供了一种工业高效的方法,用于生产一种作为药物、化学试剂、食品材料和饲料添加剂有用的L-氨基酸。该方法包括在培养基中培养一种具有产生L-氨基酸能力并对DNA酶抑制剂具有耐受性的微生物,或者一种具有产生L-氨基酸能力并同时对DNA酶抑制剂和氨基喹啉衍生物具有耐受性的微生物,在其中生产和积累L-氨基酸并从中回收L-氨基酸。
  • A pharmaceutical composition for tropical diseases
    申请人:University of Strathclyde
    公开号:EP0000291A1
    公开(公告)日:1979-01-10
    A pharmaceutical composition of prolonged effect in the treating of Tropical Diseases comprises an organic nitrogen base drug which is effective against diseases such as malaria, dispersed in a polymeric matrix of a copolymer of the compound and a comonomer which contains more than one functional group selected from hydroxy and carboxy groups.
    一种对治疗热带疾病有长期疗效的药物组合物,包括一种对疟疾等疾病有效的有机氮基药物,分散在由该化合物和共聚单体组成的聚合物基质中,共聚单体含有一个以上从羟基和羧基中选出的官能团。
  • Pharmaceutical and dietary compositions
    申请人:EFAMOL LIMITED
    公开号:EP0035856A2
    公开(公告)日:1981-09-16
    A pharmaceutical composition comprising y-linolenic acid and/or dihomo-y-linolenic acid together with a conjoint amount of a compound influencing the 1-series/2-series PG balance in the body in favour of 1-series PGs and selected from chloroquine and other 4-aminoquinolines including amodiaquine and hydroxychloroquine; diiodohydroxyquin and other 8-hydroxy and 8-aminoquinolines including iodochlorhydroxyquin, chiniofon, pentaquine, isopentaquine and primaquine; quinacrine (mepacrine) and other acridines; quinidine, quinine and procaine; emetine, metronidazole and other antiprotozoals (not already named above); and spironolactone and other modified steroids, alone or in an acceptable pharmaceutical vehicle.
    一种药物组合物,包括 y-亚麻酸和/或二羟基 y-亚麻酸,以及一定量的可影响体内 1 系/2 系 PG 平衡而有利于 1 系 PG 的化合物,该化合物选自氯喹和其他 4-氨基喹啉类,包括阿莫地喹和羟基氯喹;二碘羟喹和其他 8-羟基和 8-氨基喹啉类,包括碘氯羟喹、喹诺酮、喷他喹、异戊喹和伯 氨喹;喹那新(mepacrine)和其他吖啶类;奎尼丁、奎宁和普鲁卡因;依美汀、甲硝唑和其他抗原虫药(上文未提及);以及螺内酯和其他改良类固醇,单独使用或以可接受的药剂载体使用。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台